期刊文献+

COX模型对肝癌预后因素的分析 被引量:32

Analysis of Prognostic Factors Using Cox's Model in Patients of Liver Cancer Treated by Interventional Therapy.
下载PDF
导出
摘要 用 COX 模型,回顾性计量分析621例用导管灌注栓塞治疗的不能切除的晚期肝癌患者的预后因素。结果显示最有意义的预后因素是肿瘤大小和门静脉癌栓。1,3,5年总生存率为62.23%,12.85%和7.45%。中位存活时间为16.23月。论文结果提示对晚期肝癌最有效的治疗是栓塞治疗。有关预后因素的知识有益于患者选择治疗。 Using the Cox's proportional hazard model,we retrospectively and sta- tistically analysed 621 cases of unresectable late hepatic carcinoma treated with transcatheter arterial embolization of infusion during the period from 1986 to 1992.The results were as follows:the most significant prognostic factors were tumor size;tumor embolus in the portal vein and modality of treatment,the overall commulative survival rates for 1—,3—,and 5— year were 62.23%,12.85% and 7.45% respectively,and the median duration of survival was 16.23 months.Our findings suggested that combination therapy (LpGsTACE) is the best modality for treatment of hepatocellular carcinoma.Furthermore,knowledge of the prognostic factors is useful for the selection and management of patients.
出处 《介入放射学杂志》 CSCD 1996年第1期7-11,共5页 Journal of Interventional Radiology
关键词 肝癌 介入疗法 预后 影响因素 COX模型 Hepatic cancer Interventional therapy Affecting factors
  • 相关文献

参考文献3

  • 1贾雨辰,陆建平,田建明,王振堂.肝癌介入放射学的现状与前瞻[J].中国医学影像学杂志,1994,2(1):56-61. 被引量:13
  • 2Keiji Yamamoto,Manabu Masuzawa,Michio Kato,Takumasa Okuyama,Kazuya Tamura. Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization[J] 1992,Cancer Chemotherapy and Pharmacology(1):S77~S81
  • 3Ming-Yuh Hsieh,Wen-Yu Chang,Liang-Yen Wang,Shinn-Cherng Chen,Wan-Long Chuang,Sheng-Nan Lu,Ding-Kwo Wu. Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors[J] 1992,Cancer Chemotherapy and Pharmacology(1):S82~S85

二级参考文献4

共引文献12

同被引文献172

引证文献32

二级引证文献278

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部